Assessing & Improving Quality of Care Newly Developed Quality of Care Tools President’s Emergency Plan for AIDS Relief Track 1.0 ART Program Meeting Seema.

Slides:



Advertisements
Similar presentations
Data assessment tools to monitor and improve data quality and patient care Authors Owengah E. 1,2, Kibaara C. 1,2, Blat C. 1,3, Mutegi E. 1,2, Armes M.
Advertisements

The Evolution of an electronic Patient Information System at the Tygerberg Hospital Infectious Diseases Clinic M la Grange 10 December 2009 University.
A Training Needs Analysis of Health Workforce Competencies in HIV Care and Treatment Services in Rwanda (L305) Presented by: Dr. Peter Memiah Presented.
EHIVQUAL Review Data Submission Overview 2013 adult HIV quality of care review Customized web-based system for self-review and reporting of HIV.
Designing a National PMTCT Impact Evaluation for Option B+ in Malawi Dr. Beth A. Tippett Barr, CDC-Malawi AIDS Turning the Tide Together.
Integrated Monitoring and Evaluation of HIV Programs in Malawi Dr Andreas Jahn 1,2 1 Dept. for HIV and AIDS, MOH, Malawi 2 I-TECH Malawi.
Providing Treatment, Restoring Hope Program Evaluation and Improvement Using Small Tests Of Change Kristen A. Stafford, MPH Pat Bass, RN, MA Track 1.0.
John Aberle-Grasse CDC GAP Strategies for Building National-Scale Longitudinal Patient Monitoring Systems for HIV Treatment and Care Lusaka, October 2-5,
Utilizing Facility Data for Program Monitoring Valerie Koscelnik Track 1 ART Program Meeting Maputo, August 12, 2010.
Bobby Jefferson Senior HMIS Advisor Futures Group The Site Capacity Assessment (SCA) Tool and other Mechanisms to Monitor Transition Status Track 1 Implementers.
Cross-cutting Capacity Building Needs of Proposed Local Partners Philippe Chiliade, MD,MHA HHS / HRSA Maputo, Mozambique August 12, 2010.
Stable Outcomes and Costs in South African Patients’ Second Year on Antiretroviral Treatment Lawrence Long, Health Economics Research Office, Wits Health.
The Implementation of the WHO Asia Pacific Treatment Metrics Dr. YU, Dongbao WHO Regional Office for the Western Pacific 20 July, 2014 Antiretroviral Treatment.
HIV Care and Treatment: Benefits of Electronic Medical Records Phyllis Kanki 1, Seema Meloni 1,Beth Chaplin 1, Bolanle Banigbe 2, Prosper Okonkwo 2 1 Harvard.
(Date of presentation) (Name of presenter) UK IBD audit Biological therapies audit 2014 Comparison of (Your site name) results against the national results.
ChartWare Product Tour. Upon Log-in, view all reminders. Items in red are past-due. Use this for “internal messaging”
Presentation Title Presenter(s) Centers for Disease Control and Prevention AIDS Turning the Tide Together.
Meredith Carr, JD J. Stan Lehman, MPH David W. Purcell, JD, PhD Division of HIV/AIDS Prevention Centers for Disease Control and Prevention July 25, 2012.
Botswana National Program: Nurses Dispensing ARVs Tendani Gaolathe M.D Director Botswana-Harvard Partnership /PEPFAR Master Trainer Program.
AIDS Prevention Initiative Nigeria Monitoring and Evaluation in the Transition Toyin Jolayemi – APIN Ltd Seema Meloni - Harvard.
USING URS for QUALITY MANAGEMENT Case Study 1: “How many of the women currently enrolled in the RWCA case management program are actually receiving routine.
South Africa Data Warehouse for PEPFAR Presented by: Michael Ogawa Khulisa Management Services
Quality Assessment and Improvement Harvard – PEPFAR Tanzania, Nigeria and Botswana.
Use of routinely collected service delivery and M&E indicator data for timely feedback Denis Nash, PhD, MPH Associate Professor of Epidemiology Director,
Integrated Health Programs for Women and Children: Lessons from the Field Dr. Ambrose Misore Project Director, APHIA II Western, PATH’s Kenya Country Program.
Impact of the “Asthma Toolbox” for Improving Documentation of Pediatric Asthma Management in an Urban Community Health Center Presenter: Delaney Gracy,
Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.
Option B+ Weekly SMS reporting; data Use to improve service delivery Zikulah Namukwaya, MD, MPH MU-JHU Care /Mulago Hospital AIDS 2014 – Stepping Up The.
1 Monitoring The Patient on ARV Treatment HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Part A Treatment Adherence Site Visit reviews Kinga Cieloszyk, MD,MPH Deputy Medical Director of Clinical Care, NYCDOHMH, HIV Care, Treatment, and Housing.
Scaling up HIV Paediatric care Harvard – PEPFAR Program Chalamilla Guerino
Advanced Compliance Transport Resource Management Dean Baker Sales Director - TruTac Ltd.
Final Webinar: Reviewing the NCQA Submission Process NCQA Recognition for Patient-Centered Medical Home 2011 Standards © Qualidigm.
System Changes and Interventions: Registry as a Clinical Practice Tool Mike Hindmarsh Improving Chronic Illness Care, a national program of the Robert.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
Providing Treatment, Restoring Hope Program Updates Dr. Robb Sheneberger, MD University of Maryland School of Medicine Track 1.0 Implementers Meeting Dar.
May Maloba, CCSP Coordinator August 10,  FACES CCSP overview  Program emphasis  Screening protocols  M & E  Achievements  Challenges.
Monitoring Transition of Harvard Support to Management and Development for Health (MDH), Tanzania Mary Mwanyika-Sando, MD 8 th Annual CDC/HRSA Track 1.0.
Data dissemination meeting February 28, 2007 ICAP New York.
Office Redesign to Increase Prevention Services? Give “PEAs” a Chance Cheryl B. Aspy, Ph.D. Professor, Family & Preventive Medicine OUHSC – College of.
EXTERNAL DQA METHODOLOGY AND IMPLEMENTATION ​ Mozambique Strategic Information Project (MSIP) ​ JSI Research & Training Institute, Inc. (JSI) in collaboration.
Mövenpick Royal Palm Hotel Dar es Salaam, Tanzania August 4-6, 2009 The 7th Annual Track 1.0 ART Program Meeting.
Community-Based Adherence Support Associated with Improved Virological Suppression in Adults Receiving ART: Five-Year Outcomes from a South African Multicentre.
Visualizing data for program improvement with ICAP’s Unified Reporting System (URS): Presented by: Deborah Horowitz, Strategic Information Specialist,
Regional Dental Consultants’ Meeting Presented by Emerson Robinson, DDS, MPH Region II and V Dental Consultant.
Antiretroviral treatment programme in Thyolo district, Malawi Southern Region. MSF Luxembourg & Thyolo District Health Services - Strategic information.
EMTCT in Europe. MTCT rates, UK and Ireland, CROI 2007 Poster 761, Townsend et al diagnosed women, Low rates of MTCT from diagnosed.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
HHS/CDC Track 1.0 Transition in Rwanda Dr Ida Kankindi, Rwanda Ministry of Health Dr Felix Kayigamba, CDC-Rwanda August
1 Uses of Data from the WHO HIV Drug Resistance Strategy: 1. Monitoring of HIVDR emerging in treated groups in sentinel ART clinics HIV Drug Resistance.
Harvard PEPFAR BotswanaNigeriaTanzaniaTotal Persons enrolled in HIV Care 18,687* 91,87571, ,487* Persons initiated on ART 13,275* 118,295 61,69644,404129,375*
From Aggregate Indicators to Impacting Patients - Data Use to Inform Treatment and Improve Care Ian Wanyeki Track 1.0 Implementers Meeting Dar Es Salaam.
Priscilla Tsondai, Lynne Wilkinson, Anna Grimsrud, Angelina Trivino,
Differentiated Monitoring & Evaluation
MOVING FORWARD Enhanced ART Monitoring in Countries: Botswana
Durban, July 20th 2016 Ruggero Giuliani MSF - Mozambique
UMRG 3rd Learning Session: July 19th, 2012
Facilitating development and adaptation of the right tools
ROUTINE HEALTH INFORMATION SYSTEMS
NYSDOH AIDS Institute Quality of Care Program eHIVQUAL
Cross-sectional assessment of patient outcomes using a systematic file review process: Results from 12,987 patient files Ambereen Jaffer, Gesine Meyer-Rath,
Utilizing research as an opportunity to strengthen
Data Summit, Johannesburg
HIV Quality Improvement (QI) and the Treatment Cascade: How QI has Impacted Reach, Recruitment, Testing, Treatment, and Retention Efforts in Thailand?
Dr. Velephi Okello, Principal Investigator, MaxART Trial
Our Strategies for Viral Load Suppression
OVC_HIVSTAT HIV Risk Assessment Prototype.
Stakeholder engagement and research utilization: Insights from Namibia
Update on global progress in ART
Presentation transcript:

Assessing & Improving Quality of Care Newly Developed Quality of Care Tools President’s Emergency Plan for AIDS Relief Track 1.0 ART Program Meeting Seema Meloni, PhD, MPH Assistant Country Director, Harvard PEPFAR Nigeria 25 September 2007

Harvard PEPFAR Nigeria Two Tools for Improving Care Quality Improvement Treatment Response Utility: “Snapshot” of patient Quality Assessment Site Assessment Database

Quality Improvement

Harvard PEPFAR Nigeria Overview: Database System Electronic capture of patient data from program inception Data captured for Adult, Pediatric, and PMTCT program areas Pre- assessment Entry ARV naïve ARV experienced ART eligible ART ineligible Palliative Care Visit Lab Pharmacy ART eligible Discontinue ToxicityFailure VCT

Harvard PEPFAR Nigeria Paper records Daily entry at program sites; Merged & cleaned weekly Uploaded to Server Paper record placed in patient chart Best clinical management of patients Reports Projections Program Evaluations (QA) Downloaded in Boston; merged and reviewed Treatment Response Utility

Harvard PEPFAR Nigeria Treatment Response Utility Goal: Improve treatment process by providing clinicians quick and easy access to patients’ treatment- related data Patient ID #

Quality Assessment

Harvard PEPFAR Nigeria Evolution of Internal QA Program JSI Quality Assessments at 3 sites Informal quality improvement efforts through ongoing monitoring of site progress and visits from clinical officers Internal development of a quality assessment protocol Technical assistance on indicator selection provided by JSI Full assessment: 3 sites (different from JSI QA) Follow-up assessment on 1 site previously assessed by JSI

Harvard PEPFAR Nigeria Site Assessment Goals Assess quality of care provided to HIV/AIDS patients Identify strengths and weaknesses in clinical processes/systems Evaluate health outcomes of patients as related to clinical processes Promote accountability for patient care Facilitate the process of joint problem identification and solving

Harvard PEPFAR Nigeria Site Assessment Indicators Informed consent coverage CTX coverage TB screening coverage Lab data % Charts missing values Toxicity % patients with panic values % patients with appropriate clinical response(s) CD4 and Viral Load % patients with values at baseline, 3, 6, and 12 months % patients with CD4>200 and/or suppressing viral load at 6 and 12 months Treatment failure % patients in failure at 6 and 12 months % patients with appropriate clinical response(s)

Harvard PEPFAR Nigeria Site Assessment Database Basic procedure: Random sample of patient IDs selected from master databases. SA database preloaded with data from master Entry, Lab, Pharmacy, and Visit databases Database taken to site; data in charts compared to data loaded into SA database In addition, evaluate a few additional indicators to further evaluate quality of patient care

Harvard PEPFAR Nigeria Chart Review & Data Entry Click through tabs to access data for various indicators Data in unshaded fields are pulled from master files in Boston Fields shaded in yellow are meant for SA team to enter notes Pulled from Tx Response Utility

Harvard PEPFAR Nigeria Chart Review & Data Entry Electronic tool makes it easy for on- site analyses Jump to analysis screen and “find” all records that address given indicator

Harvard PEPFAR Nigeria Innovative Additions Red flags indicating possible virologic failureCalculator for 6- and 12-month CD4 & VL Layout that provides data summary

Harvard PEPFAR Nigeria Tools Have Improved Quality & Efficiency Treatment Response Utility Minimizes time clinician must spend reviewing patient charts Provides evaluation of adherence and treatment failures Will be adapted and used for transfer patients - allows for continuity of care Site Assessment Database Has sped up process of site assessments and allows us to evaluate our program more in-depth Allows for detailed debriefing the day after chart review is complete Can be used by sites for their own QA/QI initiatives

Thank you